Annual Short Term Debt
$2.17 M
-$7.92 M-78.52%
December 31, 2023
Summary
- As of February 8, 2025, RNAC annual short term debt is $2.17 million, with the most recent change of -$7.92 million (-78.52%) on December 31, 2023.
- During the last 3 years, RNAC annual short term debt has risen by +$1.26 million (+138.55%).
- RNAC annual short term debt is now -89.87% below its all-time high of $21.39 million, reached on December 1, 2018.
Performance
RNAC Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$2.77 M
+$247.00 K+9.79%
September 1, 2024
Summary
- As of February 8, 2025, RNAC quarterly short term debt is $2.77 million, with the most recent change of +$247.00 thousand (+9.79%) on September 1, 2024.
- Over the past year, RNAC quarterly short term debt has increased by +$541.00 thousand (+24.27%).
- RNAC quarterly short term debt is now -87.90% below its all-time high of $22.89 million, reached on March 1, 2019.
Performance
RNAC Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
RNAC Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.5% | +24.3% |
| 3 y3 years | +138.6% | -72.5% |
| 5 y5 years | -89.9% | -72.5% |
RNAC Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.5% | at low | -76.8% | +55.4% |
| 5 y | 5-year | -88.8% | +138.6% | -85.6% | +216.6% |
| alltime | all time | -89.9% | +138.6% | -87.9% | +311.6% |
Cartesian Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.77 M(+9.8%) |
| Jun 2024 | - | $2.52 M(+13.2%) |
| Mar 2024 | - | $2.23 M(+2.9%) |
| Dec 2023 | $2.17 M(-78.5%) | $2.17 M(+21.2%) |
| Sep 2023 | - | $1.79 M(-85.1%) |
| Jun 2023 | - | $11.96 M(+0.6%) |
| Mar 2023 | - | $11.89 M(+17.9%) |
| Dec 2022 | $10.08 M(+43.9%) | - |
| Dec 2022 | - | $10.08 M(+35.7%) |
| Sep 2022 | - | $7.43 M(+68.5%) |
| Jun 2022 | - | $4.41 M(+147.3%) |
| Mar 2022 | - | $1.78 M(-74.6%) |
| Dec 2021 | $7.01 M(+672.0%) | $7.01 M(+36.4%) |
| Sep 2021 | - | $5.14 M(+57.2%) |
| Jun 2021 | - | $3.27 M(+133.1%) |
| Mar 2021 | - | $1.40 M(+54.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $908.00 K(-95.3%) | $908.00 K(+3.8%) |
| Sep 2020 | - | $875.00 K(-91.3%) |
| Jun 2020 | - | $10.03 M(-45.2%) |
| Mar 2020 | - | $18.29 M(-5.1%) |
| Dec 2019 | $19.28 M(-9.9%) | $19.28 M(-11.0%) |
| Sep 2019 | - | $21.66 M(-4.3%) |
| Jun 2019 | - | $22.63 M(-1.1%) |
| Mar 2019 | - | $22.89 M(+7.1%) |
| Dec 2018 | $21.39 M(+425.8%) | $21.39 M(+0.4%) |
| Sep 2018 | - | $21.30 M(+361.8%) |
| Jun 2017 | - | $4.61 M(+2.1%) |
| Mar 2017 | - | $4.52 M(+11.1%) |
| Dec 2016 | $4.07 M(+57.8%) | $4.07 M(+39.6%) |
| Sep 2016 | - | $2.91 M(+63.6%) |
| Jun 2016 | - | $1.78 M(+164.6%) |
| Mar 2016 | - | $673.00 K |
| Dec 2014 | $2.58 M | - |
FAQ
- What is Cartesian Therapeutics annual short term debt?
- What is the all time high annual short term debt for Cartesian Therapeutics?
- What is Cartesian Therapeutics annual short term debt year-on-year change?
- What is Cartesian Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Cartesian Therapeutics?
- What is Cartesian Therapeutics quarterly short term debt year-on-year change?
What is Cartesian Therapeutics annual short term debt?
The current annual short term debt of RNAC is $2.17 M
What is the all time high annual short term debt for Cartesian Therapeutics?
Cartesian Therapeutics all-time high annual short term debt is $21.39 M
What is Cartesian Therapeutics annual short term debt year-on-year change?
Over the past year, RNAC annual short term debt has changed by -$7.92 M (-78.52%)
What is Cartesian Therapeutics quarterly short term debt?
The current quarterly short term debt of RNAC is $2.77 M
What is the all time high quarterly short term debt for Cartesian Therapeutics?
Cartesian Therapeutics all-time high quarterly short term debt is $22.89 M
What is Cartesian Therapeutics quarterly short term debt year-on-year change?
Over the past year, RNAC quarterly short term debt has changed by +$541.00 K (+24.27%)